Cost-effectiveness analysis of flucytosine as induction therapy in the treatment of cryptococcal meningitis in HIV-infected adults in South Africa

to related objects

Location: Deutsche Nationalbibliothek Frankfurt am Main

ISSN: 1472-6963

Extent: Online-Ressource

Language: Englisch

Notes: online resource.

Bibliographic citation: Cost-effectiveness analysis of flucytosine as induction therapy in the treatment of cryptococcal meningitis in HIV-infected adults in South Africa ; volume:21 ; number:1 ; day:6 ; month:4 ; year:2021 ; pages:1-11 ; date:12.2021
BMC health services research ; 21, Heft 1 (6.4.2021), 1-11, 12.2021

Creator: Miot, Jacqui
Leong, Trudy
Takuva, Simbarashe
Parrish, Andrew
Dawood, Halima

Contributor: SpringerLink (Online service)

DOI: 10.1186/s12913-021-06268-9

URN: urn:nbn:de:101:1-2021052819463087968481

Rights: Open Access; Der Zugriff auf das Objekt ist unbeschränkt möglich.

Last update: 14.08.2025, 11:02 AM CEST

Data provider

This object is provided by:
Deutsche Nationalbibliothek. If you have any questions about the object, please contact the data provider.

Show original at data provider

Associated

Miot, Jacqui
Leong, Trudy
Takuva, Simbarashe
Parrish, Andrew
Dawood, Halima
SpringerLink (Online service)

Other Objects (12)

Transcriptomic biomarker pathways associated with death in HIV-infected patients with cryptococcal meningitis

Ventriculoperitoneal shunt is associated with increased cerebrospinal fluid protein level in HIV-infected cryptococcal meningitis patients

Ventriculoperitoneal shunts in non-HIV cryptococcal meningitis

Microglia are not protective against cryptococcal meningitis

Establishment of a novel scoring model for mortality risk prediction in HIV-infected patients with cryptococcal meningitis

Ambulatory induction phase treatment of cryptococcal meningitis in HIV integrated primary care clinics, Yangon, Myanmar

Cost-effectiveness of CRAG-LFA screening for cryptococcal meningitis among people living with HIV in Uganda

Cryptococcal meningitis in a goat – a case report

Diagnostic Value of Latex Agglutination in Cryptococcal Meningitis

Prevalence of cryptococcal meningitis and lymphadenitis among PLHA

Cryptococcal antigenemia is associated with meningitis or death in HIV-infected adults with CD4 100–200 cells/mm3

Identification of Disease-Associated Cryptococcal Proteins Reactive With Serum IgG From Cryptococcal Meningitis Patients

Transcriptomic biomarker pathways associated with death in HIV-infected patients with cryptococcal meningitis

Ventriculoperitoneal shunt is associated with increased cerebrospinal fluid protein level in HIV-infected cryptococcal meningitis patients

Ventriculoperitoneal shunts in non-HIV cryptococcal meningitis

Microglia are not protective against cryptococcal meningitis

Establishment of a novel scoring model for mortality risk prediction in HIV-infected patients with cryptococcal meningitis

Ambulatory induction phase treatment of cryptococcal meningitis in HIV integrated primary care clinics, Yangon, Myanmar

Cost-effectiveness of CRAG-LFA screening for cryptococcal meningitis among people living with HIV in Uganda

Cryptococcal meningitis in a goat – a case report

Diagnostic Value of Latex Agglutination in Cryptococcal Meningitis

Prevalence of cryptococcal meningitis and lymphadenitis among PLHA

Cryptococcal antigenemia is associated with meningitis or death in HIV-infected adults with CD4 100–200 cells/mm3

Identification of Disease-Associated Cryptococcal Proteins Reactive With Serum IgG From Cryptococcal Meningitis Patients

Transcriptomic biomarker pathways associated with death in HIV-infected patients with cryptococcal meningitis

Ventriculoperitoneal shunt is associated with increased cerebrospinal fluid protein level in HIV-infected cryptococcal meningitis patients

Ventriculoperitoneal shunts in non-HIV cryptococcal meningitis

Microglia are not protective against cryptococcal meningitis

Establishment of a novel scoring model for mortality risk prediction in HIV-infected patients with cryptococcal meningitis

Ambulatory induction phase treatment of cryptococcal meningitis in HIV integrated primary care clinics, Yangon, Myanmar

Cost-effectiveness of CRAG-LFA screening for cryptococcal meningitis among people living with HIV in Uganda

Cryptococcal meningitis in a goat – a case report

Diagnostic Value of Latex Agglutination in Cryptococcal Meningitis

Prevalence of cryptococcal meningitis and lymphadenitis among PLHA

Cryptococcal antigenemia is associated with meningitis or death in HIV-infected adults with CD4 100–200 cells/mm3

Identification of Disease-Associated Cryptococcal Proteins Reactive With Serum IgG From Cryptococcal Meningitis Patients

Cultural heritage institutions wishing to register will find more information here.

Fields marked * need to be filled in.

Username*

Please enter your username

Email*

Please enter your email address

Please do not fill this field

First name

Last name

Password*

Please enter your password

Confirm password*

Please enter the same password

I have read the terms of use and the privacy policy for the collection of personal data and accept them. *

This field is required.

I would like to subscribe to the newsletter of the Deutsche Digitale Bibliothek. See newsletter subscription info.

Account created

Your "My DDB" account has been successfully created. Before you can log in to your account, you must click the confirmation link in the message we just sent to the email address you provided.

Cost-effectiveness analysis of flucytosine as induction therapy in the treatment of cryptococcal meningitis in HIV-infected adults in South Africa

Object Details

References and Relationships

Contributors, Places and Time

Further information

Data provider

Associated

Other Objects (12)

Transcriptomic biomarker pathways associated with death in HIV-infected patients with cryptococcal meningitis

Ventriculoperitoneal shunt is associated with increased cerebrospinal fluid protein level in HIV-infected cryptococcal meningitis patients

Ventriculoperitoneal shunts in non-HIV cryptococcal meningitis

Microglia are not protective against cryptococcal meningitis

Establishment of a novel scoring model for mortality risk prediction in HIV-infected patients with cryptococcal meningitis

Ambulatory induction phase treatment of cryptococcal meningitis in HIV integrated primary care clinics, Yangon, Myanmar

Cost-effectiveness of CRAG-LFA screening for cryptococcal meningitis among people living with HIV in Uganda

Cryptococcal meningitis in a goat – a case report

Diagnostic Value of Latex Agglutination in Cryptococcal Meningitis

Prevalence of cryptococcal meningitis and lymphadenitis among PLHA

Cryptococcal antigenemia is associated with meningitis or death in HIV-infected adults with CD4 100–200 cells/mm3

Identification of Disease-Associated Cryptococcal Proteins Reactive With Serum IgG From Cryptococcal Meningitis Patients

Transcriptomic biomarker pathways associated with death in HIV-infected patients with cryptococcal meningitis

Ventriculoperitoneal shunt is associated with increased cerebrospinal fluid protein level in HIV-infected cryptococcal meningitis patients

Ventriculoperitoneal shunts in non-HIV cryptococcal meningitis

Microglia are not protective against cryptococcal meningitis

Establishment of a novel scoring model for mortality risk prediction in HIV-infected patients with cryptococcal meningitis

Ambulatory induction phase treatment of cryptococcal meningitis in HIV integrated primary care clinics, Yangon, Myanmar

Cost-effectiveness of CRAG-LFA screening for cryptococcal meningitis among people living with HIV in Uganda

Cryptococcal meningitis in a goat – a case report

Diagnostic Value of Latex Agglutination in Cryptococcal Meningitis

Prevalence of cryptococcal meningitis and lymphadenitis among PLHA

Cryptococcal antigenemia is associated with meningitis or death in HIV-infected adults with CD4 100–200 cells/mm3

Identification of Disease-Associated Cryptococcal Proteins Reactive With Serum IgG From Cryptococcal Meningitis Patients

Transcriptomic biomarker pathways associated with death in HIV-infected patients with cryptococcal meningitis

Ventriculoperitoneal shunt is associated with increased cerebrospinal fluid protein level in HIV-infected cryptococcal meningitis patients

Ventriculoperitoneal shunts in non-HIV cryptococcal meningitis

Microglia are not protective against cryptococcal meningitis

Establishment of a novel scoring model for mortality risk prediction in HIV-infected patients with cryptococcal meningitis

Ambulatory induction phase treatment of cryptococcal meningitis in HIV integrated primary care clinics, Yangon, Myanmar

Cost-effectiveness of CRAG-LFA screening for cryptococcal meningitis among people living with HIV in Uganda

Cryptococcal meningitis in a goat – a case report

Diagnostic Value of Latex Agglutination in Cryptococcal Meningitis

Prevalence of cryptococcal meningitis and lymphadenitis among PLHA

Cryptococcal antigenemia is associated with meningitis or death in HIV-infected adults with CD4 100–200 cells/mm3

Identification of Disease-Associated Cryptococcal Proteins Reactive With Serum IgG From Cryptococcal Meningitis Patients

Related objects

Reset password